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Objective: To determine whether myocardial protection is improved by restoring
physiologic variability to the cardioplegia pressure signal during cardiopulmonary
bypass, we compared cardiac function in pigs in the first hour after either conven-
tional cold-blood cardioplegia (group CC) or computer-controlled biologically vari-
able pulsatile cardioplegia (group BVC).
Methods: Invasive monitors and sonomicrometry crystals were placed, and cardiopul-
monary bypass was initiated. The aorta was crossclamped, and cold blood cardioplegic
solution was infused intermittently through the aortic root with either conventional car-
dioplegia (n = 8) or biologically variable pulsatile cardioplegia (n = 8; mean pressure,
75 mm Hg for 85 minutes). The crossclamp was released, cardiac function was
restored, and separation from cardiopulmonary bypass was completed. With stable
temperature and arterial blood gases, hemodynamics and systolic and diastolic indices
were compared at 15, 30, and 60 minutes after cardiopulmonary bypass.
Results: Diastolic stiffness doubled from 0.027 ± 0.016 mm Hg/mm (mean ± SD)
at baseline to 0.055 ± 0.036 mm Hg/mm (P = .003) at 1 hour after bypass in group
CC, associated with increased left ventricular end-diastolic pressure from 9 ± 2 to
11 ± 2 mm Hg (P = .001), mean pulmonary artery pressure from 14 ± 2 to 20 ± 3
mm Hg (P = .003), and serum lactate levels from 2.0 ± 0.5 to 5.6 ± 2.3 mmol/L (P
= .008). Systolic function was not affected. In group BVC diastolic stiffness, left
ventricular end-diastolic pressure, and pulmonary artery pressure values were not
different from control values at any time after bypass, and serum lactate levels were
significantly less than with conventional cold blood cardioplegia. Peak pressure
variability with biologically variable pulsatile cardioplegia fit a power-law equation
(exponent = –3.0; R2 = 0.97), indicating fractal behavior.
Conclusion: Diastolic cardiac function is better preserved after cardiopulmonary
bypass with biologically variable pulsatile cardioplegia and fractal perfusion. This
may be attributed to enhanced microcirculatory perfusion with improved myocar-
dial protection. A model supporting these results is presented.
Ventricular dysfunction after cardiac surgery may be caused byincomplete myocardial protection during cardiopulmonarybypass (CPB) and aortic crossclamping. Optimal myocardial pro-tection depends on adequate delivery of cardioplegia solution tothe entire coronary microcirculation, but coronary blood flow dis-tribution is heterogeneous under normal conditions.1-3 With max-
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imal coronary vasodilation induced pharmacologically, 4-
fold differences in blood flow between regions can be
demonstrated, and flow variability increases at lower perfu-
sion pressures.4
The distribution of cardioplegic solution is also hetero-
geneous, even in the absence of coronary disease, and Aldea
and colleagues5 have emphasized the importance of coro-
nary perfusion pressure on delivery of cardioplegic solu-
tion. Standard cardioplegia is delivered with a roller pump
with an apulsatile flow pattern. This may not optimally
recruit all vascular territories during ischemic arrest, with
the attendant increase in vascular resistance and vessel clo-
sure. Thus, there is a high likelihood that some regions of
the myocardium may receive inadequate protection with
standard cardioplegia.
Bassingthwaighte and colleagues6,7 have suggested that
the branching pattern of the coronary circulation is fractal in
structure, which may explain the heterogeneous flow pat-
terns observed. Fractals are structures or processes that
demonstrate self-similarity with increasing magnification.
Global and regional pressure flow from the myocardium
can be mathematically modeled as simple power-law func-
tions with differing exponents.5,8,9 Such power-law func-
tions also indicate fractal behavior.
We have developed biologically variable (BV) life sup-
port, which restores the normal variability seen in physio-
logic signals to either roller pumps or mechanical
ventilators by using computer controllers.10-15 BV life sup-
port may be characterized as a fractal process because the
pressure-time relationships generated by either of the com-
puter controllers also fit power-law functions.
In the vascular system BV CPB results in improved cere-
bral oxygenation during rewarming from moderate
hypothermia compared with either apulsatile11 or monoto-
nously regular pulsatile CPB.14 Mathematic modeling sug-
gests that biologic variability, using a fractal sequence for
the driving pressure, will augment recruitment of either alve-
oli in the respiratory system16 or microvessels in the vascu-
lar system14 without an overall increase in driving pressure.
We hypothesized that infusing cardioplegic solution in a
fractal manner may enhance delivery, resulting in improved
myocardial protection during ischemic arrest.
Materials and Methods
The experiments were approved by the Committee for Animal
Experimentation at the University of Manitoba, and animals were
handled according to the standards of the Canadian Council on
Animal Care.
Surgical Preparation
Twenty healthy pigs (33-38 kg) were premedicated (atropine, 0.6
mg; ketamine, 12 mg/kg; and midazolam, 0.5 mg/kg) and anes-
thetized with isoflurane 1.4% in oxygen, with doxacurium (8
mg/h) used for muscle relaxation. Volume-cycled ventilation
through an endotracheal tube maintained arterial carbon dioxide
and pH within the normal range. Electrocardiograms were
recorded with surface electrodes.
Femoral arterial, pulmonary arterial, and urinary catheters
were placed to monitor mean arterial blood pressure, pulmonary
artery pressure, and urine volume. Through the femoral vein, an
8F balloon-tipped Fogarty catheter was passed into the inferior
vena cava above the level of the diaphragm. Nasopharyngeal and
left ventricular myocardial free-wall temperature probes were
positioned for continuous temperature monitoring.
A sternotomy was performed, and the pericardium was opened.
Left ventricular dimension was measured in 2 planes (anterior-
posterior and apex-base) by pairs of 2-mm piezo-electric ultra-
sonic transducers positioned on the endocardial surface through a
stab wound and secured with a purse-string suture. A Millar
Mikro-tip 3F catheter (Millar Instruments, Inc, Houston, Tex) was
secured in the left ventricle through the apex for continuous mea-
surement of left ventricular pressure (LVP). The crystal pairs were
attached to a digital sonomicrometer (Sonometrics Corporation,
London, Ontario, Canada).
CPB cannulas were placed in the ascending aorta (6.5 mm;
Stöckert GmbH, Freiburg, Germany) and right atrium (32F DLP
single-stage cannula; DLP, Inc, Walker, Mich). A 9F cannula
(Medtronic, Inc, Minneapolis, Minn) with a side branch for pres-
sure monitoring was inserted into the aortic root for administration
of cardioplegic solution. Before the start of CPB, 100 mg of
sodium hydrocortisol succinate was given intravenously. The
bypass circuit was primed with lactated Ringer solution (500 mL),
pentastarch (Pentaspan; 500 mL), and mannitol (Osmitrol; 500
mL) with 5000 IU of heparin to a total volume of 1.5 L. Animals
were then randomized to receive either conventional cold-blood
cardioplegia (CC) or biologically variable cardioplegia (BVC;
water bath temperature = 0°C). All hemodynamic parameters were
recorded simultaneously on a 6-channel chart recorder (Gould
Instrumentation Systems, Valley View, Ohio) and data-acquisition
system (Dataq, Codas). Echocardiography, LVP, and sonomicrom-
etry crystal data were monitored continuously on-line to the
Sonometrics computer screen and intermittently recorded for off-
line analysis.
After heparinization to an activated clotting time of greater
than 400 seconds, CPB was initiated with a flow rate of approxi-
mately 3 L/min. We used a Cobe apulsatile roller pump, mem-
brane oxygenator (Cobe Optima Hollow Fiber Open System;
Cobe Cardiovascular, Inc, Arvada, Colo), and arterial in-line filter
(Baxter 1040D 40-µm pore; Baxter Healthcare Corp, Santa Ana,
Calif) with alpha-stat pH management. Normothermic bypass was
maintained for approximately 15 minutes to ensure stable hemo-
dynamics and blood gases before placement of the aortic cross-
clamp. No vasoactive drugs were used during the bypass run. The
animals were then actively cooled to 33°C.
Protocol
Control measurements were taken after cannula placement and
before initiation of CPB. After aortic crossclamping, cardioplegia
was standardized to 20-minute cycles consisting of 5 minutes of
either CC or BVC cardioplegia at a mean perfusion pressure of 75
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mm Hg and 15 minutes of no perfusion. Five cardioplegia cycles
resulted in a total crossclamp time of 85 minutes. We used 1
minute of high-concentration KCl solution (80 mEq/L) and 4 min-
utes of low-concentration KCl solution (30 mEq/L) at a ratio of
4:1 blood/cardioplegic solution as the perfusing solution.
The computer controller and software for biologically variable
control of the roller pump have been described previously.11 In
brief, the systolic variations in arterial blood pressure obtained
from a lightly anesthetized, spontaneously breathing pig were used
to create the variability file. Minimum, maximum, and mean val-
ues for each peak systolic arterial pressure were calculated. The
minimum pressure was subtracted from each pressure, and the
new minimum (0 mm Hg), maximum, and mean peak values were
recalculated and displayed. After initiation of cardioplegia, the tar-
get mean cardioplegia pressure and maximum amount of com-
puter modulation were set. We chose a mean perfusion pressure of
75 ± 25 mm Hg pulse variation generated by the computer con-
troller. The roller-pump flow rate was adjusted to achieve the min-
imum pressure of 50 mm Hg, with the computer modulation level
preset to zero. The modulation level was then adjusted until the
increase in pump flow rate resulted in an increase in cardioplegia
pressure from 50 to 100 mm Hg, the maximum computer modula-
tion level chosen. Computer control of the roller pump was now
initiated. At any time, independent setting of the rate control could
adjust mean cardioplegia pressure to the predetermined level if
required. This setup was complete within 1 minute of initiation of
cardioplegia in all cases. Figure 1 shows the pressure profile
obtained in the aortic root with either CC or BVC over 35 seconds.
Lidocaine (2 mg/kg administered intravenously) was given 2
minutes before crossclamp release. At the end of the fifth cardio-
plegia administration, the crossclamp was released, and cardiac
activity was restored spontaneously or with internal defibrillation
(10-30 J) if necessary. No inotropic or vasoactive drugs were used.
A volume-recruitment maneuver of 3 vital capacity breaths was
performed, mechanical ventilation was resumed, and separation
from bypass was achieved.
Arterial blood gases, hemodynamics, temperatures. and car-
diac function were determined at 15, 30, and 60 minutes after
CPB. The animals were then killed with an injection of sodium
pentobarbital (Euthanol; 100 mg/kg).
Arterial Blood Gas, Temperature, and Hemodynamic
Measurements
At each measurement period, arterial and mixed venous blood
gases were sampled, and temperature was recorded. Heart rate,
mean arterial pressure, mean pulmonary artery pressure, left ven-
tricular end-diastolic pressure (LVEDP), and left ventricular end-
diastolic volume (LVEDV) were measured, and cardiac output was
determined.
Cardiac Function Determinations
At each measurement period, LVEDV was standardized visually
to control levels with transfusion. A recording of 15 to 20 heart
beats was made at end-expiration. The balloon tip of the inferior
vena cava catheter was then inflated for approximately 30 seconds
to transiently decrease left ventricular filling so that a range of
LVPs at decreasing left ventricular dimensions could be obtained.
Analysis
Postexperiment analysis of the cardiac function curves was done
with a Sonometrics software package. For each tracing, left ven-
tricular volume (LVV) was calculated from the crystal pairs by
using a 2-dimensional ellipsoid model and plotted against LVP.
Systolic Indices
First, the slope of the end-systolic pressure-volume relationship
(Emax) was determined from the cardiac function curves obtained
over successive beats of decreasing LVV during inferior vena
caval occlusion. End-systole was defined as the point in the car-
diac cycle at which elastance (LVP/LVV) was maximal. Emax was
determined by means of linear regression.
Second, preload recruitable stroke work index was determined
over the same cardiac cycles of decreasing LVV. Stroke work was
calculated as the integral of each pressure-volume loop and plot-
ted against the corresponding end-diastolic volume, the slope of
which represents preload recruitable stroke work index.
Diastolic Indices
First, the time constant for ventricular relaxation (τ) was calcu-
lated from the decline in the LVP pressure trace at stable LVEDP
and end-expiration by the following equation:
Pt = P0e(–t/τ),
where Pt is LVP at any time t, and P0 is LVP at time 0. P0 was
determined at minimal dP/dt, the start of isovolumic relaxation.
The relationship was determined with a floating asymptote, and τ
was calculated as the negative reciprocal of the slope of the fol-
lowing relationship:
lnPt = –t/τ + lnP0
Figure 1. Cardioplegia pressure waveforms as recorded from the
cardioplegia cannula to the data-acquisition system. Data have
been normalized to the same mean pressure for BVC and CC to
compare pulse pressures between groups. Data from the BVC
experiment are shown as thick black lines, and data from the CC
experiment are shown as thin black lines. Sampling rate was
every 4 ms for each curve.
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constant (Kp) according to the following equation:
LVEDP = Ce(Kp × LVV)
where C is a derived constant, Kp is chamber stiffness, and LVV
is the volume corresponding to a given end-diastolic pressure.
Fractal Model of Cardioplegia Administration
The pressure profile of cardioplegia administration (measured at
the cannula site) was analyzed post hoc in both groups. Mean peak
systolic arterial pressure (SAP) was obtained in each experiment.
Instantaneous pressure measurements (4-ms intervals) were then
determined from a representative experiment in both groups. Data
TABLE 1. Temperatures and blood gases
Before CPB 15 min after CPB 30 min after CPB 60 min after CPB
Tn (°C)
CC 36.1 ± 0.2 35.8 ± 0.4* 35.7 ± 0.5* 35.5 ± 0.6*
BVC 35.9 ± 0.3 35.6 ± 0.3* 35.4 ± 0.4* 35.5 ± 0.5*
Tv (°C)
CC 36.2 ± 0.3 35.9 ± 0.4 35.8 ± 0.4 36.0 ± 0.9
BVC 36.1 ± 0.3 35.6 ± 0.3 35.5 ± 0.4* 35.6 ± 0.5*
PaO2 (mm Hg)
CC 500 ± 46 415 ± 129 428 ± 107 451 ± 68
BVC 520 ± 31 415 ± 67 454 ± 53 475 ± 32
PaCO2 (mm Hg)
CC 39 ± 3 41 ± 6 38 ± 8 39 ± 4
BVC 39 ± 3 40 ± 5 41 ± 3 39 ± 2
Arterial pH
CC 7.43 ± 0.04 7.30 ± 0.07* 7.33 ± 0.08* 7.32 ± 0.04*†
BVC 7.43 ± 0.05 7.34 ± 0.07* 7.34 ± 0.05* 7.37 ± 0.05*
There were 8 animals in each group. Values are given as means ± SD. CPB, Cardiopulmonary bypass; Tn, nasopharyngeal temperature; Tv, central venous
temperature; PaO2, arterial partial pressure of oxygen; PaCO2, arterial partial pressure of carbon dioxide. 
*P < .05 within groups versus before CPB.
†P < .05 between groups.
TABLE 2. Hemodynamics
Before CPB 15 min after CPB 30 min after CPB 60 min after CPB
Heart rate (beats/min)
CC 100 ± 17 123 ± 35* 120 ± 29* 118 ± 22*
BVC 102 ± 14 116 ± 14* 116 ± 15* 116 ± 14*
MAP (mm Hg)
CC 70 ± 8 62 ± 11* 64 ± 15 63 ± 14
BVC 68 ± 8 62 ± 10 61 ± 8* 61 ± 8*
Cardiac output (L/min)
CC 3.2 ± 0.9 3.2 ± 0.9 3.4 ± 1.0 3.7 ± 1.2
BVC 3.0 ± 0.7 3.7 ± 1.1 3.5 ± 1.1 3.4 ± 0.7
PAP (mm Hg)
CC 14 ± 2 19 ± 3*† 19 ± 3*† 20 ± 3*†
BVC 17 ± 5 16 ± 4 16 ± 4 17 ± 3
LVEDP (mm Hg)
CC 9.9 ± 2.2 11.3 ± 2.0*† 11.4 ± 1.5*† 10.6 ± 1.7*†
BVC 9.8 ± 1.3 9.2 ± 1.8 8.8 ± 0.8 9.3 ± 1.7
LVEDV (mL)
CC 53.5 ± 16.8 50.1 ± 17.1 49.8 ± 17.1 50.9 ± 18.4
BVC 57.7 ± 11.8 57.3 ± 7.5 58.0 ± 8.7 58.1 ± 6.8
There were 8 animals in each group. Values are given as means ± SD. MAP, Mean arterial pressure; PAP, pulmonary artery pressure; LVEDP, left ventric-
ular end-diastolic pressure; LVEDV, left ventricular end-diastolic volume.
*P < .05 within groups versus before CPB.
†P < .05 between groups.
Graham et al Cardiopulmonary Support and Physiology
The Journal of Thoracic and Cardiovascular Surgery • Volume 123, Number 1   67
TX
ET
CS
P
A
CD
CH
D
CS
P
ED
IT
O
RI
A
L
were compared in the following manner: instantaneous pressure
was subtracted from mean peak SAP, and this value was squared
and then log transformed. These data were partitioned into incre-
mental bins of equal size to determine their frequency distribution.
The probability of each frequency was determined as Ni/N, where
Ni is number of observations in a given frequency bin, and N is
total number of observations. A log transformation of the proba-
bility distribution was derived. The log probability distribution
versus log SAP variation was plotted for the experiment in each
group. The equation and correlation coefficient of the data were
derived by means of regression analysis.
Cardioplegia Pressure-Flow Model
The relationship between instantaneous pressure and flow was
modeled on the canine results of Aldea and colleagues.5 Regional
myocardial pressure-flow relationships fit a family of power func-
tions of the form Q = Px, with x varying between 2.07 to 3.42. We
calculated mean cardioplegia flow by averaging instantaneous flow
from instantaneous pressures, using these 2 extremes of perfusion.
Thirty-five seconds of data from one experiment in each group
yielded 8750 instantaneous pressure measurements for this calcu-
lation. The BVC/CC mean flow ratio was compared at a pressure
normalized to 1.0 for each regional flow. Flow was then calculated
at 20%, 40%, and 50% of the normalized pressure to mimic the
decrease in perfusion pressure that may occur with increasing
downstream closing pressure during cardioplegic arrest.
Comparison of Coronary Sinus With Arterial Lactate
Concentration
We conducted 4 additional experiments in an identical model to
compare coronary sinus with arterial lactate concentration before
and after CPB. A catheter was inserted through the right atrium
deep into the coronary sinus by means of direct palpation and con-
firmed at autopsy. Cardioplegic solution was administered as in
group CC. Simultaneous coronary sinus and arterial blood samples
were obtained at baseline and after CPB. Lactate concentrations at
the 2 sites were compared with linear regression.
Statistics
Hemodynamic and systolic and diastolic cardiac indices were
compared at baseline and at each time period after CPB by a split-
plot 1-way analysis of variance for repeated measures. When sig-
nificant group or group-by-time interactions were found, least
squares means test matrices were generated, and within- and
between-group comparisons were made. The Bonferroni correc-
tion for repeated measures was applied to within-group compar-
isons. Data are presented as means ± SD unless otherwise noted.
Results
Of the 20 pigs studied, 4 were discarded from analysis: 1
before randomization with a severe inflammatory reaction
and pulmonary hypertension, 1 CC animal with lobar pneu-
monia, and 2 BVC animals, 1 for technical concerns and 1
because of aortic incompetence resulting in marked ventric-
ular distention and pulmonary hypertension during cardio-
plegia. This left 16 animals, 8 in each group, with a
complete protocol. Weights were equivalent between the 2
groups (33 ± 3 kg and 35 ± 2 kg in groups CC and BVC,
respectively; P = .29).
Temperature, Arterial Blood Gases, and Serum Lactate
Levels
Nasal and venous temperatures and end-tidal isoflurane
concentrations were stable, and arterial blood gases were
within the normal range at all measurement periods (Table
1). Temperature decreased equally during CPB (32.9°C for
the BVC group and 33.2°C for the CC group), as per the
protocol, and was restored to slightly hypothermic levels in
both groups after bypass (35.5°C-36°C). Intramyocardial
temperature fell to approximately 8.5°C during cardioplegia
and rewarmed to approximately 25°C between runs, and
this was not different between groups. Similar serum lactate
levels were present at baseline and after 60 minutes of CPB.
After CPB, serum lactate levels were higher in group CC at
every measurement period (group-by-time interaction, P =
.008; Figure 2). Comparison of 30 measurements of coro-
nary sinus to arterial lactate concentrations in the 4 post hoc
experiments described showed a highly significant correla-
tion (R2 = 0.97).
Hemodynamics
Mean arterial pressure and cardiac output were stable and
well maintained at all time periods, with no significant group-
by-time interactions (Table 2). A small increase in heart rate
was evident in both groups in the postbypass period, with no
difference between groups. Pulmonary artery pressure was
consistently higher in group CC compared with group BVC
at every measurement period after CPB, despite a lower value
at baseline (group-by-time interaction, P = .0003). LVEDP
Figure 2. Serum lactate levels over the course of the experiment in
both groups at baseline (B/L; after cannulation but before CPB), at
60 minutes of CPB, and at 15, 30, and 60 minutes after separation
from CPB. Lactate levels were significantly greater in group CC
compared with those in group BVC at every time period after CPB
(P = .008, group-by-time interaction, analysis of variance).
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was similar between groups at baseline, elevated compared
with baseline values at every postbypass period in group CC,
and not different from baseline values in group BVC. The
group-by-time interaction was not significant, but least
squares means analysis indicated a significant difference
between groups CC and BVC at every measurement period
after bypass. LVEDV was well controlled over time in each
group, with no group-by-time interaction and no difference
between groups. The absolute value of LVEDV was margin-
ally lower in group CC compared with that in group BVC
after bypass, whereas the corresponding LVEDP increased;
this is evidence of increased ventricular stiffness.
Cardioplegia Parameters
Mean cardioplegia perfusion pressures were well controlled
at 75 mm Hg in both groups. Figure 1 represents only 35
seconds of the total data set of 38 minutes for BVC. The SD
was 11.7 in group BVC and 8.4 in group CC, resulting in an
SD ratio of 1.4 in this short sequence. The mean pulse pres-
sure was 26 ± 3 mm Hg in group CC as a result of the roller
pump alone. For the entire data set, the imposition of the
BVC signal resulted in a 2.5-fold increase of this pulse
pressure to 62 ± 10 mm Hg.
Volume of cardioplegic solution was not different
between groups. Total volumes of high K+ solution deliv-
ered were 252 ± 32 mL in group CC versus 248 ± 14 mL in
group BVC. Total volumes of low K+ solution were 850 ±
134 mL in group CC versus 922 ± 98 mL in group BVC.
Cardiac Events
Five animals experienced ventricular fibrillation on cross-
clamp release in each group. Electrical defibrillation was
required 12 times in group CC and 16 times in group BVC
(not significantly different by the Fisher exact test).
Systolic Function
Emax was not different at baseline in group CC compared
with that in group BVC. The group-by-time interaction was
not significant (P = .26), although the absolute value was
slightly higher in group CC at all measurement periods after
bypass (Table 3). Within groups, there was no significant
difference in Emax at any time period compared with base-
line values. Preload recruitable stroke work index was
equivalent in both groups at baseline and remained
unchanged at every measurement period, with no signifi-
cant group-by-time interactions.
Diastolic Function
The time constant for ventricular relaxation was not
affected by mode of cardioplegia delivery, and no group-by-
time interactions were present (Table 3). Kp showed
marked differences; it was unchanged at any time period in
group BVC but doubled in group CC (P = .003) in the
immediate postbypass period and remained significantly
elevated at every measurement period after bypass between
groups (Figure 3). A significant correlation between the
change in diastolic stiffness versus the change in serum lac-
tate level after bypass is present in group CC but absent in
group BVC (Figure 4).
Fractal Model of Cardioplegia Administration
The comparison of fractal behavior of the 2 modes of car-
dioplegia delivery is shown in Figure 5. With BVC, the
power-law exponent was –3.0 (R2 = 0.97). When data from
the experiment in group CC were examined at the same bin
size as in group BVC (100 mm Hg2), all variation fell
within the first bin (P = 1.0). In fact, all observations are
within 7.6 mm Hg of the mean value.
Cardioplegia Pressure-Flow Model
The ratio of calculated normalized flow between groups
BVC and CC for each fractional normalized pressure is
shown for exponents 3.42 and 2.07 (Figure 6). Curve fitting
to the equation Q = P3.42 demonstrated a mean normalized
flow at a normalized pressure of 1.0 to be 1.09 for BVC and
1.04 for CC. The BVC/CC ratio was thus 1.05, or 5% greater
TABLE 3. Cardiac indices
Before CPB 15 min after CPB 30 min after CPB 60 min after CPB
Emax (mm Hg/mL)
CC 6.1 ± 3.2 7.8 ± 6.2 6.8 ± 5.9 7.4 ± 6.4
BVC 4.9 ± 2.6 3.9 ± 1.8* 4.3 ± 2.2* 4.7 ± 2.3*
PRSWI (mm Hg/mL)
CC 47.7 ± 8.5 44.3 ± 11.2 46.1 ± 11.9 44.5 ± 9.2
BVC 50.4 ± 6.6 51.0 ± 6.6 48.0 ± 9.3 48.2 ± 10.0
τ
CC 37 ± 7 41 ± 6 47 ± 11 41 ± 15
BVC 42 ± 8 44 ± 14 47 ± 12 47 ± 15
There were 8 animals in each group. Values are given as means ± SD. CPB, Cardiopulmonary bypass; Emax, the slope of the end-systolic pressure-
volume relationship; τ, time constant for ventricular relaxation.
*P < .05 between groups.
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flow with BVC. With the lower power-law relationship (ie,
Q = P2.07), 1% greater flow with BVC was calculated.
With decreasing normalized perfusion pressures, the
BVC/CC flow ratio increased. For the higher power-law
exponent, at a normalized perfusion pressure of 50%
of baseline, the ratio of calculated normalized flow
was 16% greater with BVC. A more modest effect (5%
greater flow with BVC) was seen with the lower power-
law exponent.
Discussion
This study demonstrates that the pressure profile used to
deliver antegrade cardioplegia can influence cardiac func-
tion in the first hour after 85 minutes of aortic crossclamp-
Figure 3. Kp versus time period after CPB. Kp was significantly
elevated after bypass in group CC (ie, approximately 100%
increase in stiffness). In contrast, Kp remained essentially
unchanged with BVC (P = .003, group-by-time interaction).
Figure 4. Change in arterial lactate concentration from baseline
versus change in Kp from baseline for the 2 experimental groups
after separation from CPB. A positive correlation is seen between
group CC data between the variables (R2 = 0.51, P < .01). No corre-
lation is evident in group BVC (R2 = 0.01, P = not significant).
Figure 5. Fractal model of cardioplegia administration with BVC.
Analysis of the peak pressure, as measured at the cardioplegia
cannula site, is shown for 1 experiment in each group. With BVC,
a power-law frequency distribution for log probability of SAP
variation versus log SAP variation is seen with a slope of –3.0.
Power-law curve fit was an R2 value of 0.97. When examined at
the same bin size (100 mm Hg2), there is no evidence of fractal
behavior with CC. This is shown as CC pooled.
Figure 6. Consequences of fractal or biologically variable delivery
of cardioplegic solution with decreasing perfusion pressure. The
BVC/CC flow ratio was calculated at 1.0, 0.8, 0.6, and 0.5 fractions
of normalized pressure for each of 2 power-law curves (ie, expo-
nent 3.42 and 2.07) on the basis of data from Aldea and col-
leagues.5 For both exponents, the normalized BVC/CC flow ratio
increases with decreasing fraction of normalized pressure; a
greater effect is seen with the higher exponent. Thus, as perfusion
pressure decreases, flow is better maintained with BVC. This is
most evident in regions of high baseline flow.
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ing and CPB in this porcine model. Systolic function was
not affected, but conventional apulsatile cardioplegia (group
CC) was associated with increases in diastolic stiffness,
LVEDP, pulmonary artery pressure, and serum lactate lev-
els. In contrast, biologically variable cardioplegia delivered
in a fractal sequence (group BVC) prevented these changes.
Diastolic dysfunction is an early indicator of myocardial
injury and may occur before changes in contractility.
Impaired diastolic dysfunction correlates to difficulty in
weaning from CPB and the need for more inotropic support
perioperatively.17 Increases in diastolic stiffness with stan-
dard cardioplegia have been well documented previously,18-20
supporting our findings. All 8 animals in group CC demon-
strated a sustained increase in Kp after CPB. With LVEDV
controlled between measurement periods, LVEDP
increased from 9 to 11 mm Hg after bypass in group CC,
which is further corroboration of a noncompliant ventricle.
Neither LVEDV nor pressure were different after bypass in
group BVC.
Buckberg21 has integrated multiple cardioprotective
strategies, including periods of warm- and cold-blood car-
dioplegia, antegrade and retrograde delivery, and intermit-
tent and continuous perfusion with both blood and
crystalloid solutions to improve myocardial protection. A
strategy to maximize distribution of cardioplegic solution
on the basis of pump-pressure profiles was not considered.
We chose a single approach to cardioplegia administration
as a model to determine whether the pressure profile for
delivery of cardioplegic solution was an important indepen-
dent parameter. The results support this contention.
Possible mechanisms to explain the benefit of BVC in
this setting include better matching of fractal delivery to a
fractal vascular bed, facilitation of vascular recruitment,
prevention of microvascular closure, and improved flow
generated with a noisy pressure profile.
Fractal Model of Cardioplegia Delivery
Fractal delivery of cardioplegia results in a more variable
perfusion pressure, although mean perfusion pressure is
identical. Figure 5 shows this difference. When analyzed
with the same yardstick of variation (ie, bin sizes of 100 mm
Hg2), BVC demonstrated a much noisier signal than that
seen with CC. Previous work suggests that collapsed vessels
may be better recruited with a noisier input signal.14 Suki
and colleagues16 have suggested that biologically variable
life support is an example of stochastic resonance, enhanced
output through use of a noisy input signal. Cardioplegia
delivery demonstrates nonlinear pressure-flow relation-
ships.5 Under such circumstances, a noisier pressure signal
results in greater flow because the decrease in flow seen at
lower pressures is more than compensated by the increase in
flow seen at greater driving pressures. The modeling based
on the curves by Aldea and colleagues5 bears this out with
greater calculated flow at the same mean pressure in group
BVC. Importantly, a greater advantage is demonstrated as
critical closing pressure increases (Figure 6).
BVC and Critical Closure
Chen and colleagues22 have demonstrated endothelial
swelling, resulting in luminal narrowing in myocardial cap-
illaries after cardioplegic arrest. Such changes increase the
propensity for vessel closure. Once closed, large increases
in pressure are necessary to reinstitute flow. Failure to
recruit vascular territories with each administration of car-
dioplegia would worsen the ischemic insult, creating a pos-
itive-feedback loop for myocardial injury. BVC may help
prevent this positive-feedback cycle. From the model, as
critical closing pressure increases (perfusion pressure 50%
of baseline value), the BVC/CC flow ratio increases (Figure
6). Thus BVC may yield a higher flow at a given perfusion
pressure to offer increased myocardial protection. Coggins
and colleagues4 have shown that at 70 mm Hg, 100% of left
ventricular areas have significant flow reserve, whereas at
30 mm Hg, equivalent to an increase in critical closing pres-
sure of 40 mm Hg, only 8% of regions had flow reserve.
Ghaleh and coworkers23 showed that areas of high baseline
flow, correlating to regions with the highest power-law
exponents, are at a 2.3-fold increased risk of myocardial
necrosis after 90 minutes of coronary occlusion in the
baboon. Thus those regions at greatest risk of ischemia are
the same regions that the flow model in Figure 6 would pre-
dict are best protected during BVC.
Limitations of the Present Study
The present study was not designed to measure either
microvascular perfusion directly or metabolic markers of
coronary perfusion, such as coronary sinus lactate levels.
However, evidence of improved coronary perfusion with
BVC is suggested indirectly by the diastolic function and
arterial lactate results obtained. The increase in serum lac-
tate levels in group CC cannot be explained by a systematic
bias in whole-body perfusion. Hemodynamics were well
matched between groups at baseline and during CPB, with
similar CPB flow rates and serum lactate levels at 60 min-
utes of CPB. There was no evidence of impaired systemic
perfusion in the postbypass period because heart rate, mean
arterial pressure, cardiac index, arterial PO2, mixed venous
PO2, and urine output were not different between groups.
With no evidence for impaired peripheral perfusion and a
strong correlation between the change in diastolic stiffness
and serum lactates, as seen in Figure 4, the results suggest
that cardiac metabolism contributed to the difference in lac-
tate concentrations seen. Follow-up work indicated a high
correlation between arterial and coronary sinus lactate lev-
els in this experimental model, suggesting that the above
conclusions are valid.
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We believe that the present study is the first to demon-
strate a benefit of increased pulse variability during cardio-
plegia delivery. Others have shown improved myocardial
function with whole-body pulsatile perfusion after various
periods of global myocardial ischemia.24-28 Although these
findings support our conjecture, others have shown no pro-
tective effect with whole-body pulsatile perfusion.27 The
present study in pigs is not directly analogous to the clini-
cal situation. The subjects were healthy young pigs, with no
evidence of coronary artery disease or left ventricular dys-
function. As such, we anticipated effects to be small. This
was borne out by a reproducible effect on diastolic stiffness
alone with a crossclamp time of 85 minutes and intermittent
cardioplegia, allowing ventricular activity to recur between
cardioplegia runs. However, the majority of patients under-
going bypass have myocardia at greater risk for incomplete
or inhomogeneous protection during aortic crossclamping
and cardioplegic arrest because of critical coronary
stenoses, ventricular dysfunction, and hypertrophy. These
preliminary results suggest that administering cardioplegia
in a fractal manner by using biologically variable pulsation
may enhance myocardial protection.
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